Pharma marketing agency
Bangalore.
India's biotech and CRO cluster — fastest-growing life sciences talent pool. ICG's pharma practice serves pharma and life sciences companies in Bangalore across scientific writing, medical communications, PSUR/DSUR, pharmacovigilance, and pharma marketing — powered by the Pharos platform.
Quick answer
What does a pharma marketing agency in Bangalore do?
A pharma marketing agency helps biotech, CRO and pharmaceutical companies reach doctors and, where the law allows, patients with accurate content: pharma SEO, medical communications, scientific and regulatory writing, HCP digital programmes and safety reports such as PSURs. Every piece passes medical, legal and regulatory review and, in India, follows the UCPMP 2024 code for promotion to healthcare professionals.
Bangalore is where
specific kinds of pharma work happen.
Bangalore is India's biotechnology and CRO capital — home to Biocon, Strides Pharma, Syngene International, and a dense ecosystem of global and Indian clinical research organisations. The city is also India's fastest-growing centre for life sciences talent, with significant R&D investment from Indian and global companies building discovery and clinical development capability. For Bangalore's biotech and specialty pharma companies, ICG's scientific writing practice is particularly relevant — companies with novel molecules or biologics need publication strategies, regulatory-grade documentation, and medical communications built by people who understand the science at the level of the researchers. IIT BHU pharmaceutical engineers bring exactly that.
What does a medical communications agency do?
A medical communications (“med comms”) agency turns clinical and scientific data into accurate material for doctors, medical affairs teams and, where the law allows, the public. For Bangalore’s biotech, CRO and specialty pharma companies, the work usually follows the product lifecycle:
| Stage | Typical med comms and marketing work |
|---|---|
| Pre-launch | Publication planning, manuscripts and congress abstracts, advisory-board and KOL decks, disease-awareness content |
| Launch | HCP detailing aids and e-detailing, MSL training material, launch symposia, HCP-gated product websites |
| Growth | CME programmes, real-world evidence publications, HCP newsletters, LinkedIn and email programmes to doctors |
| Mature or off-patent | Line-extension communication, safety updates, PSUR/PBRER writing and lifecycle publications |
Every piece goes through medical, legal and regulatory (MLR) review before release. In India, promotion to healthcare professionals also has to follow the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024.
How is pharma SEO different from ordinary SEO?
Pharma SEO has to win search visibility without breaking the rules on promoting medicines. The differences that matter most:
- Two audiences, two content sets. Disease-awareness and patient-support content can be public; product and prescribing information is usually for healthcare professionals, often behind an HCP gate. In India, prescription medicines cannot be advertised to the public, and the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 bars claims to treat listed conditions.
- Every page needs MLR sign-off. Build templates and a claims library that reviewers have already approved, so SEO updates do not wait weeks.
- Trust signals carry more weight. Health content falls under Google’s “Your Money or Your Life” standard: name the medical reviewer, cite sources and show review dates.
- Structured data such as
MedicalWebPage,Drug(where appropriate) andOrganizationhelps search engines understand the page. - AI answers. Google’s AI Overviews and assistants now answer many disease and treatment questions, so clear, well-sourced pages are more likely to be cited.
Doctors are reachable online: ICG’s Pharma B2B Marketing Benchmark India 2026 estimates that roughly 62% of prescriber decision journeys now include at least one digital touchpoint before a first medical representative visit. See also our pharma marketing practice and guide to outsourcing medical writing to India.
Updated 8 October 2026.
Five practice areas.
Available locally and remotely.
Scientific Writing & MedComm
Manuscripts, systematic reviews, abstracts, KOL decks, MSL materials. CONSORT/PRISMA/STROBE embedded from Day 1.
Explore practice →PSUR / DSUR / PBRER Writing
Periodic safety reports. ICH E2C and E2F compliant. 4-layer sequential QC. Audit-ready by design.
Explore practice →Pharmacovigilance Services
Literature monitoring, ICSR writing, signal detection. Powered by Pharos Scout, Vigil, Deploy.
Explore practice →Pharma Marketing
Brand campaigns, CLM, e-detailing, visual aids, HCP engagement, digital marketing.
Explore practice →Scientific Writing
Journal publications powered by Pharos Scribe. AI-guided journal fit. CONSORT/PRISMA/STROBE.
Explore practice →
Nine modules. One intelligence layer.
Built for the specific frictions of pharma.
Every ICG pharma engagement runs on some combination of these nine modules. The engagement scope determines which ones are active on day one.
Explore the full Pharos platform →Every ICG pharma engagement runs on some combination of these nine modules. The pilot engagement determines which ones are active from Day 1.
Start a pilot project →
Led by a pharma specialist.
IIT BHU-founded leadership team.
Every ICG pharma engagement is led personally by Aditi Tripathi — M.Pharm, IIT BHU — with Abhash, Deep and Rohit (Co-Founding Team) bringing the scientific rigour, delivery architecture and commercial lens built across 8+ years. IIT BHU pharmaceutical engineers at every level of the engagement.
100+ specialists. One process. Every deliverable in-house. Gurgaon, since 2018.
Abhash Kumar
Strategy Lead · IIT BHU + IIM Bangalore
Leads scientific strategy and quality governance. Sets the standard for scientific rigour across every engagement.
Profile →
Deep Das
Operations Lead · IIT BHU (B.Tech + M.Tech)
Owns the AI-powered delivery system — the multi-tenant operations layer that runs every pharma engagement on time and on spec.
Profile →
Rohit Gupta
Business & Growth Lead · IIT BHU + IIM Rohtak
Pharma engineer who owns business growth and the commercial lens connecting science to prescription outcomes.
Profile →
Aditi Tripathi
IIT BHU · M.Pharm
Aditi leads every pharma engagement end to end — from scoping the scientific writing architecture to governing quality across delivery. Her M.Pharm from IIT BHU means she doesn't need the science explained to her. "She explains it to everyone else."
Pharma in Bangalore.
Start with a pilot.
ICG runs in-person scoping calls in Bangalore where geography permits — and full remote engagements where it doesn't. The pilot decides whether the partnership is right.
Related reading
- Selling to hospitals, doctors or distributors? See our healthcare B2B marketing agency page.
- Comparing pharma partners? Read our roundup of pharma marketing agencies in India.
Common questions
What does "med comms" mean?
Med comms is short for medical communications: the scientific content pharmaceutical, biotech and device companies produce for healthcare professionals and medical affairs teams. It includes publications, congress materials, advisory-board and training decks, medical education and disease-awareness content, all checked through medical, legal and regulatory review before release.
What is SEO in healthcare and pharma?
Healthcare and pharma SEO is search optimisation for medical content: making disease information, product information for professionals and company pages easy to find while following the rules on promoting medicines. It relies on accurate, reviewed content, clear structure and trust signals such as named medical reviewers and sources, because search engines hold health topics to a higher standard.
Can pharma companies advertise prescription medicines online in India?
Not to the general public. Prescription medicines can be promoted only to registered healthcare professionals, under the Drugs and Cosmetics rules and the UCPMP 2024 code, and the Drugs and Magic Remedies Act bars advertising claims to treat listed conditions. Public content is limited to disease awareness and general health information without promoting a specific prescription product.
